mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
8e-08 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-07 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-07 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-07 |
mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
4e-07 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
5e-07 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
6e-07 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
6e-07 |
mRNA |
PIK-93 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
6e-07 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
7e-07 |